This is the authors' abstract. We don't add key points for this paper.
Posaconazole is widely used for prophylaxis against invasive fungal infections in patients undergoing myeloablative therapy. Disseminated fusariosis is a serious invasive mold infection in such patients. Preclinical and clinical studies indicate activity of posaconazole against Fusarium. We describe two cases of disseminated fusariosis that occurred despite posaconazole prophylaxis.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bose et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: